LABB.MX
LABB.MX
MX01LA010006
GENOMMA LAB INTERNACIONAL SAB
Loading chart...

Company Profile

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Related stocks

HYPE3.SA
HYPE3.SA • Brazil
HYPERA ON EJ NM
26.93 BRL
3.8B USD 1Y +29%
4534.T
4534.T • Japan
MOCHIDA PHARMACEUTICAL CO
3,075 JPY
682.51M USD 1Y -1.6%
4105.TWO
4105.TWO • Taiwan
TTY BIOPHARM COMPANY LIMITED
80.9 TWD
630.39M USD 1Y +0.6%
PHN.MI
PHN.MI • Italy
PHARMANUTRA
71.1 EUR
762.88M USD 1Y +42.7%
600351.SS
600351.SS • China
YABAO PHARMACEUTICAL GROUP CO L
7.07 CNY
732.07M USD 1Y +6.8%
300039.SZ
300039.SZ • China
SHANGHAI KAIBAO
5.39 CNY
843.62M USD 1Y -11.8%
300194.SZ
300194.SZ • China
FUAN PHARM
4.03 CNY
717.42M USD 1Y -7.8%
603567.SS
603567.SS • China
HEILONGJIANG ZBD PHARMACEUTICAL
5.4 CNY
759.73M USD 1Y -53.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.5% p.a.
Max Drawdown (5Y)
-57.4%
Sharpe Ratio (5Y)
-0.30
Beta Factor
0.13
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -57.4% in the extended horizon.
ende